Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism EGFR antagonists(Epidermal growth factor receptor erbB1 antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
RegulationSpecial Review Project (CN) |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Non-Small Cell Lung Cancer | Phase 2 | CN | 03 Jul 2015 | |
Non-Small Cell Lung Cancer | Phase 2 | CN | 03 Jul 2015 | |
Advanced Malignant Solid Neoplasm | Phase 1 | CN | 03 Jul 2015 | |
Advanced Malignant Solid Neoplasm | Phase 1 | CN | 03 Jul 2015 |